AVVAA COMPLETES DISTRIBUTOR PACT WITH GALAMAN.
Lorie Campbell-Farley, EVP Sales and Marketing for avVaa said, "While full commercialization of other lines at avVaa is on-going, we are committed to researching and developing our secondary lines of equine and pet products to meet the needs of one of the fastest growing segments of the retail market, now a $31 billion industry."
Campbell-Farley continued, "A nationally recognized distributor like Galaman has the ability to strategically place our equine, vet and pet product lines on a national level. We look forward to a mutually beneficial relationship as we move forward in this important sector."
avVaa Care and avVaa Vet products were developed utilizing the healing powers of avVaa's Neuroskin formulas providing the Equine and Pet Industry with all natural patented nano-fine mineral solution products that quickly treat many skin disorders common to animals.
About Galaman Ltd.
Galaman Ltd. is a Canadian company specializing in innovative equine and small animal products for distribution to 350 plus equine Veterinary Practices and 3000 plus small animal Veterinary Practices throughout Canada. Galaman Ltd was developed to provide the equine athlete and small animals with only the highest quality products to enhance, promote and maintain their physical condition.
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. avVaa is poised to manufacture and market its O-T-C Neuroskin line of skin care products through mass, food and drug channels in the United States and globally.
For more information, visit: http://www.avvaa.com or http://www.otcfn.com/avvw or call 604/688-2349.
|Printer friendly Cite/link Email Feedback|
|Date:||Feb 1, 2006|
|Previous Article:||AASTROM BIOSCIENCES REPORTS POSITIVE HUMAN JAW BONE RESULTS.|
|Next Article:||NORWOOD IMMUNOLOGY TAKES OPTION FOR VACCINE TECHNOLOGY.|